Kapsner, Lorenz A. http://orcid.org/0000-0003-1866-860X
Balbach, Eva L.
Folle, Lukas
Laun, Frederik B.
Nagel, Armin M. http://orcid.org/0000-0003-0948-1421
Liebert, Andrzej
Emons, Julius
Ohlmeyer, Sabine
Uder, Michael
Wenkel, Evelyn
Bickelhaupt, Sebastian
Funding for this research was provided by:
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 10 November 2022
Accepted: 20 June 2023
First Online: 29 June 2023
Competing interests
: Sebastian Bickelhaupt reports financial support was provided by German Federal Ministry of Education and Research (BMBF) - FKZ 161B0976. Sebastian Bickelhaupt reports a relationship with Siemens Healthcare GmbH that includes: speaking and lecture fees. Eva Balbach reports a relationship with Siemens Healthcare GmbH that includes: speaking and lecture fees. Michael Uder reports a relationship with Siemens Healthcare GmbH that includes: member of the speakers bureau. The University Hospital Erlangen receives funding from Siemens Healthcare GmbH that is partially contributing to the job positions of Sebastian Bickelhaupt and Lorenz Kapsner. Julius Emons reports relationships with Pfizer Pharma GmbH, Novartis AG, and Eisai GmbH that include: speaking and lecture fees, participation on an advisory board, travel support (from Novartis AG). Lukas Folle, Frederik Laun, Armin Nagel, Andrzej Liebert, Sabine Ohlmeyer, and Evelyn Wenkel declare no potential competing interests.